Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease

被引:46
作者
Jones, Tara L. Spires [1 ]
Mielke, Matthew L. [1 ]
Rozkalne, Anete [1 ]
Meyer-Luehmann, Melanie [1 ]
de Calignon, Alix [1 ]
Bacskai, Brian J. [1 ]
Schenk, Dale [2 ]
Hyman, Bradley T. [1 ]
机构
[1] Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis, Charlestown, MA USA
[2] Elan, San Francisco, CA USA
关键词
Alzheimer; Dendritic spine; Immunotherapy; Mouse model; Structural plasticity; LONG-TERM POTENTIATION; TRANSGENIC MICE; NATURAL OLIGOMERS; BETA PLAQUES; SPINE LOSS; IN-VIVO; ABNORMALITIES; IMMUNIZATION; MEMORY; PDAPP;
D O I
10.1016/j.nbd.2008.10.011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Senile plaque-associated changes in neuronal connectivity such as altered neurite trajectory, dystrophic swellings, and synapse and dendritic spine loss are thought to contribute to cognitive dysfunction in Alzheimer's disease and mouse models. Immunotherapy to remove amyloid beta is a promising therapy that causes recovery of neurite trajectory and dystrophic neurites over a period of days. The acute effects of immunotherapy on neurite morphology at a time point when soluble amyloid has been cleared but dense plaques are not yet affected are unknown. To examine whether removal of soluble amyloid beta (A beta) has a therapeutic effect on dendritic spines, we explored spine dynamics within 1 h of applying a neutralizing anti A beta antibody. This acute treatment caused a small but significant increase in dendritic spine formation in PDAPP brain far from plaques, without affecting spine plasticity near plaques or average dendritic spine density. These data support the hypothesis that removing toxic soluble forms of amyloid-beta rapidly increases structural plasticity possibly allowing functional recovery of neural circuits. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 40 条
  • [1] Bacskai BJ, 2002, J NEUROSCI, V22, P7873
  • [2] Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
    Bard, F
    Cannon, C
    Barbour, R
    Burke, RL
    Games, D
    Grajeda, H
    Guido, T
    Hu, K
    Huang, JP
    Johnson-Wood, K
    Khan, K
    Kholodenko, D
    Lee, M
    Lieberburg, I
    Motter, R
    Nguyen, M
    Soriano, F
    Vasquez, N
    Weiss, K
    Welch, B
    Seubert, P
    Schenk, D
    Yednock, T
    [J]. NATURE MEDICINE, 2000, 6 (08) : 916 - 919
  • [3] Anti-Aβ antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice
    Brendza, RP
    Bacskai, BJ
    Cirrito, JR
    Simmons, KA
    Skoch, JM
    Klunk, WE
    Mathis, CA
    Bales, KR
    Paul, SM
    Hyman, BT
    Holtzman, DM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) : 428 - 433
  • [4] A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease
    Chen, GQ
    Chen, KS
    Knox, J
    Inglis, J
    Bernard, A
    Martin, SJ
    Justice, A
    McConlogue, L
    Games, D
    Freedman, SB
    Morris, RGM
    [J]. NATURE, 2000, 408 (6815) : 975 - 979
  • [5] Natural oligomers of the amyloid-protein specifically disrupt cognitive function
    Cleary, JP
    Walsh, DM
    Hofmeister, JJ
    Shankar, GM
    Kuskowski, MA
    Selkoe, DJ
    Ashe, KH
    [J]. NATURE NEUROSCIENCE, 2005, 8 (01) : 79 - 84
  • [6] In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories
    D'Amore, JD
    Kajdasz, ST
    McLellan, ME
    Bacskai, BJ
    Stern, EA
    Hyman, BT
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (02) : 137 - 145
  • [7] Neuroanatomical abnormalities in behaviorally characterized AppV717F transgenic mice
    Dodart, JC
    Mathis, C
    Saura, J
    Bales, KR
    Paul, SM
    Ungerer, A
    [J]. NEUROBIOLOGY OF DISEASE, 2000, 7 (02) : 71 - 85
  • [8] Behavioral disturbances in transgenic mice overexpressing the V717F β-amyloid precursor protein
    Dodart, JC
    Meziane, H
    Mathis, C
    Bales, KR
    Paul, SM
    Ungerer, A
    [J]. BEHAVIORAL NEUROSCIENCE, 1999, 113 (05) : 982 - 990
  • [9] Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
    Dodart, JC
    Bales, KR
    Gannon, KS
    Greene, SJ
    DeMattos, RB
    Mathis, C
    DeLong, CA
    Wu, S
    Wu, X
    Holtzman, DM
    Paul, SM
    [J]. NATURE NEUROSCIENCE, 2002, 5 (05) : 452 - 457
  • [10] ALZHEIMER-TYPE NEUROPATHOLOGY IN TRANSGENIC MICE OVEREXPRESSING V717F BETA-AMYLOID PRECURSOR PROTEIN
    GAMES, D
    ADAMS, D
    ALESSANDRINI, R
    BARBOUR, R
    BERTHELETTE, P
    BLACKWELL, C
    CARR, T
    CLEMENS, J
    DONALDSON, T
    GILLESPIE, F
    GUIDO, T
    HAGOPIAN, S
    JOHNSONWOOD, K
    KHAN, K
    LEE, M
    LEIBOWITZ, P
    LIEBERBURG, I
    LITTLE, S
    MASLIAH, E
    MCCONLOGUE, L
    MONTOYAZAVALA, M
    MUCKE, L
    PAGANINI, L
    PENNIMAN, E
    POWER, M
    SCHENK, D
    SEUBERT, P
    SNYDER, B
    SORIANO, F
    TAN, H
    VITALE, J
    WADSWORTH, S
    WOLOZIN, B
    ZHAO, J
    [J]. NATURE, 1995, 373 (6514) : 523 - 527